SENSEX NIFTY

Breast Cancer Drug

Jan 18, 2017 at 15:16 | Source: Moneycontrol.com
Zydus Cadila has received the final approval from the USFDA to market Methotrexate tablets USP, 2.5 mg, a chemotherapy drug used for leukemias, lymphomas, breast cancer, lung cancer, and head and neck cancer and other cancers.
Jan 12, 2017 at 09:44 | Source: Moneycontrol.com
Biocon shares touched a record high of Rs 1,049.50 on Thursday, up nearly 5 percent intraday after the US health regulator has accepted biosimilar application for its proposed cancer drug.
Jan 12, 2017 at 08:43 | Source: CNBC-TV18
Following US president-elect Donald Trumps explosive speech last night where he lambasted the domestic pharma companies for outsourcing work, pharma stocks are likely to be in limelight today.
Jan 12, 2017 at 08:21 | Source: Moneycontrol.com
Bengaluru-based biopharmaceutical firm Biocon on Wednesday said US drug regulator has accepted its partners Mylans biologics license application (BLA) for the proposed biosimilar of breast cancer drug Trastuzumab through the 351(k) pathway.
Jan 09, 2017 at 19:25 | Source: Reuters
Japan's Takeda Pharmaceutical Co Ltd said on Monday it would buy cancer drug maker Ariad Pharmaceuticals Inc in a deal valued at USD5.20 billion, to beef up its oncology pipeline.
Jan 06, 2017 at 14:56 | Source: PTI
"Pursuant to the settlement of the Paragraph IV litigation, Natco plans to launch this drug on November 1, 2019, or earlier under certain circumstances, through its marketing partner Breckenridge Pharmaceutical, Inc in the USA market," it added.
Dec 28, 2016 at 13:44 | Source: PTI
Metformin is the most widely prescribed drug for the treatment of type 2 diabetes. Besides its blood sugar lowering effect, it also displays anti-cancer properties. The usual therapeutic dose is too low to effectively fight cancer.
Dec 27, 2016 at 15:41 | Source: Moneycontrol.com
This study was the last major step of a multiple-phased programme to demonstrate that proposed biosimilar trastuzumab meets the criteria for equivalence in comparison to branded trastuzumab.
Dec 13, 2016 at 14:24 | Source: PTI
The company has received an approval from the United States Food and Drug Administration (USFDA) for Capecitabine tablets USP in the strengths of 150 mg and 500 mg, Shilpa Medicare said in a BSE filing.
Dec 13, 2016 at 13:38 | Source: Moneycontrol.com
Shilpa Medicare shares gained nearly 3 percent intraday Tuesday after getting approval for anti-cancer chemotherapy drug.
Messages on Breast Cancer Drug »

Khushi1979

New Member

0 Follower

GAIL  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

10.55 AM Jan 19th

k.v.renga

Platinum Member

1377 Followers

Biocon  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

9.48 PM Jan 18th

Web Messenger

Platinum Member

369230 Followers

News Now  

Source:Wall Street Journal - By Marta Falconi ZURICH (Dow Jones)--Positive fresh data on Roche Holding AG's (ROG.VX) newest breast cancer drug is expected to be displayed in the US next month at a high-profile medical meeting. Roche is planning to present additional data from key

4.43 PM May 22nd 2012

Web Messenger

Platinum Member

369230 Followers

News Now  

Source:Bloomberg - An experimental breast cancer drug from Roche Holding AG (ROG) that carries chemotherapy directly into malignant cells while bypassing healthy ones delayed tumors longer and with fewer side effects than an established therapy.

12.31 AM Jun 8th 2012

Web Messenger

Platinum Member

369230 Followers

News Now  

Source:Forbes - An experimental breast cancer drug being developed by tiny Celldex Therapeutics of Needham., Mass., appeared to show a potent tumor-shrinking effect in four women who had both an especially hard-to-treat form of breast cancer and whose tumors had high levels of the protein targeted

7.25 PM May 27th 2012

Web Messenger

Platinum Member

369230 Followers

News Now  

Source:Forbes - An experimental breast cancer drug being developed by tiny Celldex Therapeutics of Needham., Mass., appeared to show a potent tumor-shrinking effect in four women who had both an especially hard-to-treat form of breast cancer and whose tumors had high levels of the protein targeted

12.55 PM May 27th 2012

News across the web »
Apr 15, 2014 at 14:00 | Source: Bloomberg
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.